On April 13, 2022, the Head of the Board and Leading Researcher of UIPHP Sergii Dvoriak took part in a meeting of international experts in the field of public health, organized by Johns Hopkins Bloomberg School of Public Health (USA).

About 17,000 people in Ukraine rely on opioid agonist therapy. Chaotic wartime conditions endanger their treatment. 

In a Global Health NOW exclusive, Head of the Board and Leading Researcher of UIPHP Sergii Dvoriak discussed working through supply and other challenges to help his team's study populations in dozens of hospitals, clinics, and medical centers across the country.

Buprenorphine was approved by the US Food and Drug Administration (FDA) in 2002 to treat opioid use disorder and pain.

The eleventh revision of the International Classification of Diseases, developed and annually updated by the World Health Organization, came into effect on 1 January 2022.

Іn a new report launched ahead of World AIDS Day, UNAIDS issued a stark warning today that if leaders fail to tackle inequalities the world could face 7.7 million.

On October 20-22, the International Conference, organized by the International Association of Providers of AIDS Care (IAPAC), takes place in a hybrid format both virtually and in-person in Lisbon, Portugal.

The annual Global Report on Tuberculosis from the World Health Organization has been published.

A five-year project aimed at developing and disseminating substance maintenance treatment (SMT) programs in Ukraine has been completed. On September 28, during an online meeting, the project partners discussed its results and plans for the future.